Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

Clinical trial NCT05081401 · RECRUITING

Trial details

NCT number: NCT05081401
Sponsor: Huashan Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multidrug Resistant Tuberculosis Rifampicin Resistant Tuberculosis Pre-XDR-TB

Start date: 2022-05-23
Primary completion: 2026-12-01
Enrollment: 1050

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.